Study 175, an unpublished and preliminary comparison of Avandia and Actos by GSK researchers. Study 175 data indicate that Actos lowers blood levels of triglycerides, a cardiovascular risk factor ...

Fighting to revive a class action, a lawyer for health plans told the Third Circuit on Wednesday that GlaxoSmithKline fumbled its responsibility to warn about the diabetes drug Avandia’s link to ...

Washington (CNN)-- A Food and Drug Administration committee delivered a split verdict on the diabetes drug Avandia on Wednesday, with most members voting to leave it on the market but recommending ...

An US Food and Drug Administration panel of medical advisors is expected to begin a two-day meeting today to revisit the six-year-old debate regarding the safety of GSK's diabetes drug ...

A Senate report says GlaxoSmithKline knew of potential heart attack risks from its Avandia diabetes medication before they were made public. knew about potential cardiac risks from its Avandia ...

The drugmaker’s own evidence shows that it could have added a warning to Avandia’s label regarding the drug’s cardiovascular health risks in 2005 but never made a formal application to make a label ...

It was a busy year for drug news and issues, so we've put together a list of drug-safety reports, warnings, analyses, and regulatory actions by the Food and Drug Administration that should prompt ...

Next month, the Obama-era US Food and Drug Administration (FDA) will confront what is likely to be the most defining moment in its short history. In a public meeting scheduled for mid-July, a ...

Two thiazolidinediones are available in the U.S.: pioglitazone (Actos) and rosiglitazone (Avandia). However, researchers have raised concerns about the cardiovascular safety of these drugs.

According to Avandia.com, "Avandia can cause or worsen heart failure". There has been growing concern regarding Avandia, which was released to the market 10 years ago for people with type 2 diabetes.

Examples of these medications include: Diabeta (glyburide) Avandia (rosiglitazone) Invokana (canagliflozin) Januvia (sitagliptin) However, other options are available, including some injectable ...